In collaboration with the Carer Group, the Center has developed a Clinical Trial Demographic Scorecard system designed to provide an objective, quantitative assessment of participant representation in clinical trials supporting new drug approvals. Ensuring adequate and balanced representation in clinical research remains essential for producing generalizable, high-quality evidence. The Scorecard offers a standardized framework to track participant demographics and evaluate progress in achieving comprehensive representation across therapeutic areas and study phases. This approach enhances transparency in trial reporting, supports data-driven oversight, and strengthens confidence in the applicability of clinical findings to broad patient populations.